CD8A and cancer: Since ICIs treatment did not lower the high risk of death in PWH with cancer whose CD4 count and CD4:CD8 ratio were low, Assoumou et al.’s findings support the significance of CD4 count and CD4:CD8 ratio in the prognosis of PWH with cancer [29].